Decrease of hormone binding capacity of estrogen receptor by calcium

Journal of Receptor and Signal Transduction Research

Volumn 17, Issue 6, 1997, Pages 833-853

  Maaroufi, Y ^a   Hardouze, A Ben ^a   Leclercq, G ^a  

^a JULES BORDET INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EDETIC ACID; ESTRADIOL; ESTROGEN RECEPTOR; IODINE 125; TAMOXIFEN AZIRIDINE;

ARTICLE; CALCIUM CELL LEVEL; CONFORMATIONAL TRANSITION; HORMONE RECEPTOR INTERACTION; HUMAN; ISOTOPE LABELING; PROTEIN CONFORMATION; PROTEIN DEGRADATION; RECEPTOR AFFINITY;

EID: 1842367879     PISSN: 10799893     EISSN: None     Source Type: Journal    
DOI: 10.3109/10799899709039159     Document Type: Article

References (40)

1. Puca, G.A.; Nola, E.; Sica, V.; and Bresciani, F. Estrogen-binding protein of calf uterus. Partial purification and preliminary characterization of two cytoplasmic proteins. Biochemistry 10, 3769-3780, 1971.
2. Puca, G.A.; Nola, E.; Sica, V.; and Bresciani, F. Estrogen-binding proteins of calf uterus. Interrelationship between various forms and identification of a receptor transforming factor. Biochemistry 11, 4157-4165, 1972.
3. 2+ and salt on forms of estradiol cytoplasmic receptor in human neoplasmic breast tissue. Cancer Res. 37, 382-387, 1977.
4. Tilzer, L.L.; McFarland, R.T.; Plapp, F.V.; Evans, J.P.; and Chiga, M Different ionic forms of receptor in rat uterus and human breast carcinoma. Cancer Res. 41, 1058-1063, 1981.
5. 2+-calmodulin. Molec. Endocrinol. 2, 167-174, 1988.
6. Bouhoute, A.; and Leclercq, G. Antagonistic effect of triphenylethylenic antiestrogens on the association of estrogen receptor to calmodulin. Biochem. Biophys. Res. Commun. 184, 1432-1440, 1992.
7. Bouhoute, A.; and Leclercq, G. Modulation of estradiol and DNA binding to estrogen receptor upon association with calmodulin. Biochem. Biophys. Res. Commun. 208, 748-755, 1995.
8. 2, temperature and oestradiol on the uterine cytosol receptor of oestradiol. Biochimie 53, 893-907, 1971.
9. Ree, A.H.; Landmark, B.F.; Walaas, S.I.; Lahooti, H.; Eikvar, L.; Eskild, W.; and Hansson, V. Down-regulation of messenger ribonucleic acid and protein levels for estrogen receptors by phorbol ester and calcium in MCF-7 cells. Endocrinology 129, 339-344, 1991.
10. Turgeon, J.L.; and Waring, D.W. Functional cross-talk between receptors for peptide and steroid hormones. Trends Endocrinol. Metab. 3, 360-365, 1992.
11. Wooge, C.H.; Nilsson, G.M.; Heierson, A.; McDonnell, D.P.; and Katzenellenbogen, B.S. Structural requirements for high affinity ligand binding by estrogen receptors: a comparative analysis ot truncated and full length estrogen receptors expressed in bacteria, yeast, and mammalian cells. Mol. Endocrinol. 6, 861-869, 1992.
12. European Organization for Research and Treatment of Cancer. Breast Cancer Cooperative Group. Revision of the standards for the assessment of hormone receptors in human breast cancer. Report of the second E.O.R.T.C. workshop, held March 16-17 in The Netherlands Cancer Institue, Eur. J. Cancer 16, 1513-1515, 1980.
13. Quivy, J.; Leclercq, G.; Deblaton, M.; Henrot, P.; Velings, N.; Norberg, B.; Evrard, G.; and Zeicher, M. Synthesis, structure and biological properties of Z-17α-(2-iodovinyl)-11β-chloromethyl estradiol-17ß, a high affinity ligand for the characterization of estrogen receptor-positive tumors. J. Steroid Biochem. Molec. Biol. 59, 103-117, 1996.
14. Garola, R.E.; and McGuire, W.L. Estrogen receptor and proteolytic activity in human breast tumor nuclei. Cancer Res. 37, 3329-3332, 1977.
15. Maaroufi, Y.; and Leclercq, G. Importance of A/B and C domains of the estrogen receptor for its adsorption to hydroxylapatite. J. Steroid Biochem. Molec. Biol. 48, 155-163, 1994.
16. Scatchard, G. The attraction of proteins for small molecules and ions. Ann. NY Acad. Sci. 51, 660-672, 1949.
17. Greene, G.L.; Sobel, N.B.; King, W.J.; and Jensen, E.V. Immunochemical studies of estrogen receptors. J. Steroid Chem. 20, 51-56, 1984.
18. Piccart, M.; Muquardt, C.; Bosman, C.; Pirotte, P.; Veenstra, S.; Grillo, F.; and Leclercq, G. Comparison between tritiated estradiol and tamoxifen aziridine for measuring estrogen receptors in human breast cancer cytosols. J. Natl. Cancer Inst. 83, 1553-1559, 1991.
19. Bouhoute, A.; and Leclercq, G. Calmodulin decreases the estrogen binding capacity of the estrogen receptor. Biochem. Biophys. Res. Commun. 227, 651-657, 1996.
20. Braunsberg, H.; Killen, E.; and Richardson, S.G. The effect of thiols on estradiol binding by components of human malignant breast tumours. Biochem. J. 130, 38P, 1972.
21. Bresciani, F.; Nola, E.; Sica, V.; and Puca, G.A. Early stages in estrogen control of gene expression and its derangement in cancer. Fed. Proc. 32, 2126-2132, 1973.
22. Puca, G.A.; Nola, E.; Sica, V.; and Bresciani, F. Estrogen binding proteins of calf uterus. J. Biol. Chem. 252, 1358-1366, 1977.
23. Sherman, M.R.; Pickering, L.A.; Rollwagen, P.M.; and Miller, L.K. Mero-receptors: proteolytic fragments of receptors containing the steroid binding site. Fed. Proc. 37, 167-173, 1978.
24. Gorbunoff, M.J.; and Timasheff, S.N. The interaction of proteins with hydroxyapatite. III. Mechanism. Anal. Biochem. 136, 440-445, 1984.
25. Stability Constants of Metal Ion Complexes. Special Publication No17, the Chemical Society. London, Burlington House, 1964.
26. Stability Constants of Metal Ion Complexes. Special Supplement No1. Metalcalf, Cooper Ltd.; London, 1971.
27. Castoria, G.; Migliaccio, A.; Green, S.; Di Dominico, M.; Chambon, P; and Auricchio, F. Properties of a purified estradiol dependent calf uterus tyrosine kinase. Biochemistry 32, 1740-1751, 1993.
28. Arnold S.F.; Vorojeikina, D.P.; and Notides, A.C. Phosphorylation of a tyrosine 537 on the human estrogen receptor is required for binding to an estrogen response element. J. Biol. Chem. 270, 30205-30212, 1995.
29. Le Goff, P.; Montano, M.M.; Schodin, D.J.; and Katzenellenbogen B.S. Phosphorylation of human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activity. J. Biol. Chem. 269, 4458-4466, 1994.
30. Marsigliante, S.; Baker, V.A.; Puddefoot, J.; Baker, S.; and Vinson, G.P. 4 S estrogen receptor isoforms and their distribution m breast cancer samples. J. Mol. Endocrinol. 7, 205-211, 1991.
31. Arnold, S.F.; Obourn, J.D.; Jaffe, H.; and Notides, A.C. Phosphorylation of the human estrogen receptor on tyrosine 537 in vivo and by src family tyrosine kinases in vitro. Molec. Endocrinol. 9, 24-33, 1995.
32. Weis K.E.; Ekena, K.; Thomas, J.A.; Lazennec, G.; and Katzenellenbogen, B.S. Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein. Mol. Endocrinol. 10, 1388-1398, 1996.
33. Bökenkamp, D.; Jungblut, P.W.; and Thole, H.H. The C-terminal half of the porcine estradiol receptor contains no post-translational modification: determination of the primary structure. Molec. Cel. Endocrinol. 104, 163-172, 1994.
34. Tiselius, A.; Hjertén, S.; and Levin, Ö. Protein chromatography on calcium phosphate columns. Arch. Biochem. Biophys. 65, 132-155, 1956.
35. Muller, R.E.; Traish, A.M.; and Wotiz, H.H. Estrogen receptor activation precedes transformation. Effects of ionic strength, temperature, and molybdate. J. Biol. Chem. 258, 9227-9236, 1983.
36. DeBoer, W.; and Notides, A.C. Dissociation kinetics of the nuclear estrogen receptor. Biochemistry 20, 1290-1294, 1981.
37. Muller, R.E.; Traish, A.M.; Hirota, T.; Bercel, E.; and Wotiz, H.H. Conversion of estrogen receptor from a state with low affinity for estradiol into a state of higher affinity does not require 4S to 5S dimerization. Endocrinology 116, 337-345, 1985.
38. Schoenberg, D.R.; and Clark, J.H. A simple modification of the estrogen receptor exchange assay: validation in nuclei from the rat uterus and a mouse mammary tumor. Endocrinology 106, 56-60, 1980.
39. Maino, V.C.; Green, N.M.; and Crumton, M.J. The role of Ca ions in initiating transformation of lymphocytes. Nature 251, 324-327, 1974.
40. Freedman, M.H.; Raff, M.C.; and Gomperts, B. Induction of increased calcium uptake in mouse T lymphocytes by concanavalin A and its modulation by cyclic nucleotides. Nature 255, 378-382, 1975.